Research graph
References from Astragalus polysaccharide loaded MF59 adjuvant system enhances vaccine-induced cellular immune responses. Local targets link to admitted publications; unresolved targets remain external evidence.
Emerging concepts in the science of vaccine adjuvants
10.1038/s41573-021-00163-y · 2021 · External reference
Research progress on emulsion vaccine adjuvants
10.1016/j.heliyon.2024.e24662 · 2024 · External reference
The history of MF59® adjuvant: A phoenix that arose from the ashes
10.1586/erv.12.140 · 2013 · External reference
Immunology and efficacy of MF59-adjuvanted vaccines
10.1080/21645515.2018.1495301 · 2018 · External reference
Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses
10.1016/j.jconrel.2022.07.032 · 2022 · External reference
Vaccine adjuvants: Mechanisms and platforms
10.1038/s41392-023-01557-7 · 2023 · External reference
MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine
10.4161/hv.19229 · 2012 · External reference
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
10.1016/j.vaccine.2007.11.054 · 2008 · External reference
Adjuvant system AS01: Helping to overcome the challenges of modern vaccines
10.1080/14760584.2016.1213632 · 2017 · External reference
Identification of QS-21 as an inflammasome-activating molecular component of saponin adjuvants
10.1074/jbc.m115.683011 · 2016 · External reference
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
10.1038/s41570-020-00244-3 · 2021 · External reference
QS-21: A potent vaccine adjuvant
10.4172/2329-6836.1000e113 · 2015 · External reference
The matrix-MTM adjuvant: A critical component of vaccines for the 21st century
10.1080/21645515.2023.2189885 · 2023 · External reference
Immune enhancing properties of the novel matrix-MTM adjuvant leads to potentiated immune responses to an influenza vaccine in mice
10.1016/j.vaccine.2013.01.039 · 2013 · External reference
Polysaccharides derived from Chinese medicinal herbs: A promising choice of vaccine adjuvants
10.1016/j.carbpol.2021.118739 · 2022 · External reference
Application prospect of polysaccharide in the development of vaccine adjuvants
10.1016/j.ijbiomac.2025.139845 · 2025 · External reference
Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice
10.1016/j.intimp.2012.09.006 · 2012 · External reference
Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: A review
10.1016/j.biopha.2022.113541 · 2022 · External reference
Astragalus polysaccharide enhances the immune function of RAW264.7 macrophages via the NF-κB p65/MAPK signaling pathway
10.3892/etm.2020.9452 · 2021 · External reference
Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo
10.1038/srep44822 · 2017 · External reference
pH-responsive Astragalus polysaccharide-loaded PLGA nanoparticles as an adjuvant system to improve immune responses
10.1016/j.ijbiomac.2022.09.283 · 2022 · External reference
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
10.1016/j.addr.2021.113889 · 2021 · External reference
A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells
10.1016/s0022-1759(02)00013-3 · 2002 · External reference
Formulation of dry powders of vaccines containing MF59 or AddaVax by thin-film freeze-drying: Towards a dry powder universal flu vaccine
10.1016/j.ijpharm.2022.122021 · 2022 · External reference
Structural features and biological activities of the polysaccharides from Astragalus membranaceus
10.1016/j.ijbiomac.2013.12.002 · 2014 · External reference
Preparation, complexation mechanism and properties of Nano-complexes of Astragalus polysaccharide and amphiphilic chitosan derivatives
10.1016/j.carbpol.2016.12.068 · 2017 · External reference
Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells
10.1016/s0005-2736(97)00126-0 · 1997 · External reference
